Cover Image
市場調查報告書

三次元細胞培養的全球市場的預測 ∼2021年:癌症細胞研究、細胞化驗分析、毒性篩檢

3D Cell Culture Market by Technology (Scaffold Based, Scaffold Free), Application (Cancer Cell Research, Cell-based Assays/Toxicity Screening), End-Users (Biotechnology & Pharmaceuticals Industries) and Geography- Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 363063
出版日期 內容資訊 英文 177 Pages
訂單完成後即時交付
價格
Back to Top
三次元細胞培養的全球市場的預測 ∼2021年:癌症細胞研究、細胞化驗分析、毒性篩檢 3D Cell Culture Market by Technology (Scaffold Based, Scaffold Free), Application (Cancer Cell Research, Cell-based Assays/Toxicity Screening), End-Users (Biotechnology & Pharmaceuticals Industries) and Geography- Global Forecast to 2021
出版日期: 2016年07月05日 內容資訊: 英文 177 Pages
簡介

全球三次元細胞培養的市場,預計從2016年到2021年以23.6%的年複合成長率 (CAGR) 發展,從2016年的4億6680萬美元,成長到2021年13億4520萬美元的規模。在預測期間中支架型的成長顯著,支架的材料、結構的選項豐富成為其要素。

本報告提供全球三次元細胞培養的市場調查,市場及技術概要,影響市場成長因素及市場機會分析,各技術、用途、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 富有魅力的市場機會

第5章 三次元細胞培養的市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 推動要素
    • 阻礙因素
    • 市場機會
    • 課題

第6章 三次元細胞培養的市場分析:各技術

  • 簡介
  • 支架型
    • 水凝膠/ECM類比
    • 固態支架
    • 微圖案表面
  • 無支架型
    • 超低黏合板
    • 3D培養皿
    • 微流體
    • 懸滴板
    • 3D生物反應器
    • 磁浮 & 3D生物印刷

第7章 三次元細胞培養的市場分析:各用途

  • 簡介
  • 癌症細胞研究
  • 細胞化驗分析/毒性篩檢
  • 再生醫療/組織工程
  • 幹細胞體外用途
  • 3D列印/微流體
  • 其他

第8章 三次元細胞培養的市場分析:各終端用戶

  • 簡介
  • 醫藥品、生物科技產業
  • 研究實驗室、機關
  • 醫院、診斷中心
  • 其他

第9章 三次元細胞培養的地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 其他
  • 其他地區

第10章 三次元細胞培養的競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢
    • 收購
    • 擴張
    • 聯盟
    • 新產品的投入

第11章 企業簡介

  • THERMO FISHER SCIENTIFIC, INC.
  • LONZA GROUP AG
  • CORNING INC.
  • REALBIO TECHNOLOGY, INC.
  • GLOBAL CELL SOLUTIONS, INC.
  • KURARAY CO. LTD.
  • HAMILTON COMPANY
  • BANGALORE INTEGRATED SYSTEM SOLUTIONS (P) LTD.
  • HIMEDIA LABORATORIES
  • REPROCELL INCORPORATED
  • BELLBROOK LABS
  • CELLNTEC ADVANCED CELL SYSTEMS AG
  • QGEL SA
  • BECTON, DICKINSON AND COMPANY (BD)
  • MERCK KGAA
  • UPM
  • VITRO BIOPHARMA
  • PELOBIOTECH GMBH
  • SYNTHECON, INC.
    • 概要
    • 財務趨勢
    • 產品與服務
    • 策略
    • 發展趨勢等

第12章 附錄

目錄
Product Code: BT 4414

The global 3D cell culture market size is expected to reach USD 1345.2 million by 2021 from USD 466.8 million in 2016, at a CAGR of 23.6%. The global 3D cell culture market is segmented based on technology, application, end user, and region. The scaffold-based segment is expected to register the highest growth rate in the 3D cell culture market, by technology, during the forecast period. The high growth in this segment is attributed to the variety of material and structural choices for scaffold, due to which they are most preferred in various applications.

Based on end users, the 3D cell culture market is segmented into research laboratories & institutes, biotechnology & pharmaceutical industries, and hospitals & diagnostic centers. The biotechnology & pharmaceutical industries segment is expected to account for the largest share of the market in 2016. Increasing prevalence of cancer cases and the need for development of advanced drugs and therapies will drive the growth of this market.

Geographically, the 3D cell culture market is dominated by North America, followed by Europe, Asia-Pacific, and Rest of the World (RoW). Growth in the North American segment is primarily driven by rising incidences of cancer, increasing government support in the form of grants and funding, expanding biopharmaceutical industry, and launch of new products in the market.

The major factors contributing to the growth of the 3D cell culture market include increasing incidences of cancer, growing awareness regarding the benefits of 3D cell culture, rising regulatory approvals for cell culture-based vaccines, funding for cell-based research, and technological advancements. On the other hand, high cost of cell biology research and lack of infrastructure for cell-based research in emerging economies are the major factors restraining the growth of this market. The high growth potential in the Asia-Pacific region provides growth opportunities to players in the 3D cell culture market.

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the 3D cell culture market.

The major players in this market include 3D Biotek LLC (U.S.), Becton, Dickinson and Company (U.S.), Corning Incorporated (U.S.), Thermo Fisher Scientific (U.S.), Global Cell Solutions, Inc. (U.S.), Kuraray Co. Ltd. (Japan), Lonza Group (Switzerland), Merck & Co., Inc. (U.S.), Sigma Aldrich Corporation (U.S.), Reinnervate Ltd, (a subsidiary of ReproCELL) (U.K.), and others.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the 3D cell culture market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the 3D cell culture market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the 3D cell culture market
  • Market Development: Comprehensive information about emerging markets
  • Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the 3D cell culture market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKETS COVERED
    • 1.3.1. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. LUCRATIVE OPPORTUNITIES IN THE 3D CELL CULTURE MARKET

5. MARKET OVERVIEW

    • 5.1.1. INTRODUCTION
    • 5.1.2. MARKET SEGMENTATION
    • 5.1.3. 3D CELL CULTURE MARKET SEGMENTATION, BY TECHNOLOGY
    • 5.1.4. 3D CELL CULTURE MARKET SEGMENTATION, BY APPLICATION
    • 5.1.5. 3D CELL CULTURE MARKET SEGMENTATION, BY END USER
    • 5.1.6. 3D CELL CULTURE MARKET SEGMENTATION, BY REGION
  • 5.2. MARKET DYNAMICS
  • 5.3. DRIVERS
    • 5.3.1. RISING INVESTMENT IN RESEARCH RELATED ACTIVITIES
    • 5.3.2. TECHNOLOGICAL ADVANCEMENTS
    • 5.3.3. FUNDING FOR CELL-BASED RESEARCH
  • 5.4. RESTRAINTS
    • 5.4.1. HIGH COST OF CELL BIOLOGY RESEARCH
    • 5.4.2. LACK OF INFRASTRUCTURE FOR 3D CELL-BASED RESEARCH IN EMERGING ECONOMIES
  • 5.5. OPPORTUNITIES
    • 5.5.1. RISING DEMAND FOR ORGAN TRANSPLANTATION
    • 5.5.2. INCREASE IN R&D SPENDING
  • 5.6. CHALLENGES
    • 5.6.1. LACK OF CONSISTENCY IN 3D CELL CULTURE PRODUCTS

6. 3D CELL CULTURE MARKET, BY TECHNOLOGY

  • 6.1. INTRODUCTION
  • 6.2. SCAFFOLD-BASED
    • 6.2.1. HYDROGELS/ECM ANALOGS
    • 6.2.2. SOLID SCAFFOLDS
    • 6.2.3. MICROPATTERNED SURFACES
  • 6.3. SCAFFOLD-FREE
    • 6.3.1. ULTRA-LOW ATTACHMENT PLATES
    • 6.3.2. 3D PETRI DISH
    • 6.3.3. MICROFLUIDICS
    • 6.3.4. HANGING DROP PLATES
    • 6.3.5. 3D BIOREACTORS
    • 6.3.6. MAGNETIC LEVITATION & 3D BIOPRINTING

7. 3D CELL CULTURE MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. CANCER CELL RESEARCH
  • 7.3. CELL BASED ASSAY/TOXICITY SCREENING
  • 7.4. REGENERATIVE MEDICINE/TISSUE ENGINEERING
  • 7.5. IN VIVO APPLICATIONS FOR STEM CELLS
  • 7.6. 3D PRINTING/MICROFLUIDICS
  • 7.7. OTHERS

8. 3D CELL CULTURE MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES
  • 8.3. RESEARCH LABORATORIES & INSTITUTES
  • 8.4. HOSPITALS & DIAGNOSTIC CENTERS
  • 8.5. OTHERS

9. 3D CELL CULTURE MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
    • 9.2.3. MEXICO
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. U.K.
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. REST OF EUROPE
  • 9.4. ASIA-PACIFIC
    • 9.4.1. JAPAN
    • 9.4.2. CHINA
    • 9.4.3. INDIA
    • 9.4.4. SOUTH KOREA
    • 9.4.5. AUSTRALIA
    • 9.4.6. REST OF ASIA-PACIFIC
  • 9.5. REST OF THE WORLD (ROW)

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. ACQUISITIONS
    • 10.3.2. EXPANSIONS
    • 10.3.3. PARTNERSHIPS
    • 10.3.4. NEW PRODUCT LAUNCHES

11. COMPANY PROFILES (Overview, Financial*, Products & Services, Strategy, and Developments)

  • 11.1. THERMO FISHER SCIENTIFIC, INC.
  • 11.2. LONZA GROUP AG
  • 11.3. CORNING INC.
  • 11.4. REALBIO TECHNOLOGY, INC.
  • 11.5. GLOBAL CELL SOLUTIONS, INC.
  • 11.6. KURARAY CO., LTD
  • 11.7. HAMILTON COMPANY
  • 11.8. BANGALORE INTEGRATED SYSTEM SOLUTIONS (P) LTD.
  • 11.9. HIMEDIA LABORATORIES
  • 11.10. REPROCELL INCORPORATED
  • 11.11. BELLBROOK LABS
  • 11.12. CELLNTEC ADVANCED CELL SYSTEMS AG
  • 11.13. QGEL SA
  • 11.14. BECTON, DICKINSON AND COMPANY (BD)
  • 11.15. MERCK KGAA
  • 11.16. UPM
  • 11.17. VITRO BIOPHARMA
  • 11.18. PELOBIOTECH GMBH
  • 11.19. SYNTHECON, INC.

*Details might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: 3D CELL CULTURE MARKET, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 2: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 3: SCAFFOLD-BASED 3D CELL CULTURE MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 4: HYDROGEL/ECM ANALOGS MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 5: SOLID SCAFFOLD MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: MICROPATTERNED SURFACES MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: SCAFFOLD-FREE MARKET, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 8: SCAFFOLD-FREE MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: ULTRA-LOW ATTACHMENT PLATES MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: 3D PETRI DISH MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: MICROFLUIDICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: HANGING DROP PLATES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: 3D BIOREACTOR MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: MAGNETIC LEVITATION & 3D BIOPRINTING MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 16: CANCER CELL RESEARCH MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: CELL BASED ASSAY/TOXICITY SCREENING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: REGENERATIVE MEDICINE/TISSUE ENGINEERING, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: IN VIVO APPLICATIONS FOR STEM CELLS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: 3D PRINTING/MICROFLUIDICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: OTHERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL 3D CELL CULTURE MARKET, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 23: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: 3D CELL CULTURE MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2016-2021 (USD MILLION)
  • TABLE 25: 3D CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2016-2021 (USD MILLION)
  • TABLE 27: 3D CELL CULTURE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: NORTH AMERICA: 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 84  
  • TABLE 29: NORTH AMERICA: 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 30: NORTH AMERICA: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 31: NORTH AMERICA: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 32: U.S. SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 33: U.S. SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 34: U.S. : 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 35: U.S.: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 36: CANADA: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 37: CANADA: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 38: CANADA: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 39: CANADA: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 40: MEXICO: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 41: MEXICO: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 42: MEXICO: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 43: MEXICO: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 44: EUROPE: 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: EUROPE: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 46: EUROPE: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 47: EUROPE: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 48: EUROPE: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 49: GERMANY: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 50: GERMANY: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 51: GERMANY: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 52: GERMANY: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 100  
  • TABLE 53: FRANCE: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 54: FRANCE: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 55: FRANCE: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 56: FRANCE: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 57: FRANCE: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 58: FRANCE: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 59: U.K.: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 60: U.K.: 3D CELL CULTURE MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 61: ITALY: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 62: ITALY: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 63: ITALY: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 64: ITALY: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 65: SPAIN: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 66: SPAIN: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 67: SPAIN: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 68: SPAIN: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 69: REST OF EUROPE: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 70: REST OF EUROPE: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 71: REST OF EUROPE: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 72: REST OF EUROPE: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 73: ASIA-PACIFIC: 3D CELL CULTURE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 74: ASIA-PACIFIC: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 75: ASIA-PACIFIC: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 76: ASIA-PACIFIC: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 115  
  • TABLE 77: ASIA-PACIFIC: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 78: JAPAN: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021(USD MILLION)
  • TABLE 79: JAPAN: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021(USD MILLION)
  • TABLE 80: JAPAN: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 81: JAPAN: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 82: CHINA: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 83: CHINA: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 84: CHINA: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 85: CHINA: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 86: INDIA: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 87: INDIA: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 88: INDIA: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 89: INDIA: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 90: SOUTH KOREA: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 91: SOUTH KOREA: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 92: SOUTH KOREA: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 93: SOUTH KOREA: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 94: AUSTRALIA: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 95: AUSTRALIA: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 96: AUSTRALIA: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 97: AUSTRALIA: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 98: REST OF ASIA-PACIFIC: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 99: REST OF ASIA-PACIFIC: SCAFFOLD-FREE 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 100: REST OF ASIA-PACIFIC: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 128  
  • TABLE 101: REST OF ASIA-PACIFIC: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 102: REST OF THE WORLD: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 103: REST OF THE WORLD: SCAFFOLD-BASED 3D CELL CULTURE MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 104: REST OF THE WORLD: 3D CELL CULTURE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 105: REST OF THE WORLD: 3D CELL CULTURE MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 106: ACQUISITIONS, 2014-2015
  • TABLE 107: EXPANSIONS, 2015
  • TABLE 108: PARTNERSHIPS, 2013
  • TABLE 109: AGREEMENTS, 2013-2016
  • TABLE 110: NEW PRODUCT LAUNCHES, 2014

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: THE SCAFFOLD-BASED TECHNOLOGY SEGMENT IS EXPECTED TO LEAD THE GLOBAL 3D CELL CULTURE MARKET DURING THE FORECAST PERIOD
  • FIGURE 7: CANCER CELL RESEARCH SEGMENT LED THE GLOBAL 3D CELL CULTURE APPLICATION MARKET IN 2015
  • FIGURE 8: BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRIES AND RESEARCH LABORATORIES & INSTITUTES ARE MAJOR END USERS OF THE GLOBAL 3D CELL CULTURE MARKET
  • FIGURE 9: NORTH AMERICA LED THE GLOBAL 3D CELL CULTURE MARKET IN 2015
  • FIGURE 10: GLOBAL 3D CELL CULTURE MARKET TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
  • FIGURE 11: HYDROGEL/ECM ANALOGS TECHNOLOGY SEGMENT DOMINATED THE GLOBAL 3D CELL CULTURE MARKET
  • FIGURE 12: ASIA-PACIFIC MARKET TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 13: 3D CELL CULTURE MARKET SEGMENTATION
  • FIGURE 14: 3D CELL CULTURE MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 15: 3D CELL CULTURE MARKET SEGMENTATION, BY END USER
  • FIGURE 16: 3D CELL CULTURE MARKET SEGMENTATION, BY REGION
  • FIGURE 17: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: 3D CELL CULTURE MARKET, BY TECHNOLOGY
  • FIGURE 19: SCAFFOLD-BASED SEGMENT LED THE 3D CELL CULTURE MARKET IN 2015
  • FIGURE 20: HYDROGELS/ECM ANALOGS ACCOUNTED FOR THE LARGEST SHARE OF THE SCAFFOLD-BASED 3D CELL CULTURE MARKET IN 2015
  • FIGURE 21: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE SCAFFOLD-BASED 3D CELL CULTURE MARKET IN 2015
  • FIGURE 22: NORTH AMERICA LED THE HYDROGEL/ECM ANALOGS SEGMENT OF THE SCAFFOLD-BASED 3D CELL CULTURE MARKET IN 2015
  • FIGURE 23: EUROPE LED THE SOLID SCAFFOLDS SEGMENT OF THE SCAFFOLD-BASED 3D CELL CULTURE MARKET IN 2015
  • FIGURE 24: EUROPE LED THE MICROPATTERNED SURFACES SEGMENT OF THE SCAFFOLD-BASED 3D CELL CULTURE MARKET IN 2015
  • FIGURE 25: HANGING DROP PLATES IS EXPECTED TO BE THE FASTEST-GROWING SEGMENT OF THE SCAFFOLD-FREE 3D CELL CULTURE MARKET
  • FIGURE 26: NORTH AMERICA EXPECTED TO BE THE FASTEST-GROWING REGIONAL SEGMENT OF THE SCAFFOLD-FREE 3D CELL CULTURE MARKET
  • FIGURE 27: NORTH AMERICA LED THE ULTRA-LOW ATTACHMENT PLATES SEGMENT OF THE SCAFFOLD-FREE 3D CELL CULTURE MARKET IN 2015
  • FIGURE 28: NORTH AMERICA LED THE 3D PETRI DISH SEGMENT OF THE SCAFFOLD-FREE 3D CELL CULTURE MARKET IN 2015
  • FIGURE 29: NORTH AMERICA LED THE MICROFLUIDS TECHNOLOGY SEGMENT OF THE SCAFFOLD-FREE 3D CELL CULTURE MARKET IN 2015
  • FIGURE 30: NORTH AMERICA LED THE HANGING DROP PLATES SEGMENT OF THE SCAFFOLD-FREE 3D CELL CULTURE MARKET IN 2015
  • FIGURE 31: NORTH AMERICA LED THE 3D BIOREACTORS SEGMENT OF THE SCAFFOLD-FREE 3D CELL CULTURE MARKET IN 2015
  • FIGURE 32: NORTH AMERICA LED THE MAGNETIC LEVITATION & 3D BIOPRINTING SEGMENT OF THE SCAFFOLD-FREE 3D CELL CULTURE MARKET IN 2015
  • FIGURE 33: 3D CELL CULTURE MARKET, BY APPLICATION
  • FIGURE 34: THE CANCER CELL RESEARCH SEGMENT LED THE 3D CELL CULTURE MARKET IN 2015
  • FIGURE 35: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE 3D CELL CULTURE MARKET FOR CANCER CELL RESEARCH IN 2015
  • FIGURE 36: NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE 3D CELL CULTURE MARKET FOR CELL BASED ASSAY/TOXICITY SCREENING IN 2015
  • FIGURE 37: ASIA-PACIFIC ESTIMATED TO GROW AT THE HIGHEST CAGR IN THE 3D CELL CULTURE MARKET FOR REGENERATIVE MEDICINE/TISSUE ENGINEERING
  • FIGURE 38: NORTH AMERICA ESTIMATED TO DOMINATE THE 3D CELL CULTURE MARKET FOR IN VIVO APPLICATIONS FOR STEM CELLS IN 2016
  • FIGURE 39: EUROPE PROJECTED TO BE THE FASTEST-GROWING REGION IN THE 3D CELL CULTURE MARKET FOR 3D PRINTING/MICROFLUIDICS
  • FIGURE 40: EUROPE ESTIMATED TO BE THE FASTEST-GROWING REGION IN THE 3D CELL CULTURE MARKET FOR OTHER APPLICATIONS
  • FIGURE 41: GLOBAL 3D CELL CULTURE MARKET, BY END USER
  • FIGURE 42: GLOBAL 3D CELL CULTURE MARKET, BY END USER, 2016 & 2021 (USD MILLION)
  • FIGURE 43: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES, 2016 & 2021, BY REGION (USD MILLION)
  • FIGURE 44: 3D CELL CULTURE MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2016 & 2021 (USD MILLION)
  • FIGURE 45: 3D CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2016 & 2021 (USD MILLION)
  • FIGURE 46: 3D CELL CULTURE MARKET FOR OTHER END USERS, 2016 & 2021, BY REGION (USD MILLION)
  • FIGURE 47: 3D CELL CULTURE MARKET IN EUROPE TO GROW AT THE HIGHEST RATE (2016 TO 2021)
  • FIGURE 48: NORTH AMERICA: 3D CELL CULTURE MARKET SNAPSHOT
  • FIGURE 49: SCAFFOLD-BASED TECHNOLOGY LED THE NORTH AMERICAN 3D CELL CULTURE MARKET IN 2015
  • FIGURE 50: CANCEL CELL RESEARCH TO DOMINATE THE NORTH AMERICAN 3D CELL CULTURE MARKET BY APPLICATION IN 2015
  • FIGURE 51: BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES ESTIMATED TO FORM THE LARGEST SEGMENT IN THE NORTH AMERICAN 3D CELL CULTURE MARKET IN 2015
  • FIGURE 52: EUROPE: 3D CELL CULTURE MARKET SNAPSHOT
  • FIGURE 53: SCAFFOLD-BASED TECHNOLOGY ESTIMATED TO BE THE LARGEST SEGMENT OF 3D CELL CULTURE MARKET IN EUROPE
  • FIGURE 54: THE CANCER CELL RESEARCH SEGMENT LED 3D CELL CULTURE MARKET, IN 2015
  • FIGURE 55: THE BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRIES SEGMENT LED THE 3D CELL CULTURE MARKET IN EUROPE IN 2015
  • FIGURE 56: ASIA-PACIFIC 3D CELL CULTURE MARKET SNAPSHOT
  • FIGURE 57: SCAFFOLD-BASED EXPECTED TO BE THE LARGEST SEGMENT OF THE 3D CELL CULTURE MARKET IN ASIA-PACIFIC IN 2016
  • FIGURE 58: CANCER CELL RESEARCH EXPECTED TO BE THE LARGEST SEGMENT OF THE 3D CELL CULTURE MARKET IN ASIA-PACIFIC IN 2016
  • FIGURE 59: BIOTECHNOLOGY & PHARMACEUTICAL INDUSTRIES EXPECTED TO BE THE LARGEST SEGMENT OF THE 3D CELL CULTURE MARKET IN ASIA-PACIFIC IN 2016
  • FIGURE 60: LEADING MARKET PLAYERS ADOPTED BOTH ORGANIC AND INORGANIC GROWTH STRATEGIES OVER THE LAST FOUR YEARS (2013-2016)
  • FIGURE 61: GLOBAL 3D CELL CULTURE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 62: BATTLE FOR MARKET SHARE: ACQUISITIONS, EXPANSIONS, AND PARTNERSHIPS ARE THE KEY STRATEGIES
  • FIGURE 63: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 64: LONZA GROUP AG: COMPANY SNAPSHOT
  • FIGURE 65: CORNING INC.: COMPANY SNAPSHOT
  • FIGURE 66: KURARAY CO., LTD: BUSINESS OVERVIEW
  • FIGURE 67: REPROCELL INCORPORATED: BUSINESS OVERVIEW
  • FIGURE 68: BD: BUSINESS OVERVIEW
  • FIGURE 69: COMPANY SNAPSHOT: MERCK MILLIPORE
  • FIGURE 70: UPM: COMPANY SNAPSHOT
  • FIGURE 71: VITRO BIOPHARMA: COMPANY SNAPSHOT
Back to Top